Hyperfractionated radiation therapy and concurrent chemotherapy for advanced head and neck cancer.


PURPOSE To investigate the feasibility of combining hyperfractionated radiotherapy regimen with concomitant chemotherapy and to assess its toxicity in patients with advanced head and neck carcinoma (HNC). Progression free survival (PFS) and overall survival (OS) were set as secondary end points. PATIENTS AND METHODS Between November 2003 and November 2007… (More)


  • Presentations referencing similar topics